Aging & Longevity

ENHO and EDN1 variants link adropin-endothelin-1 imbalance with early vascular aging in adults with and without type 2 diabetes.

TL;DR

Combined ENHO-EDN1 genetic burden is associated with an adverse adropin-endothelin-1 balance and early vascular aging in adults with and without T2DM, though independent replication is required before clinical application.

Key Findings

All four ENHO and EDN1 variants were associated with early vascular aging (EVA) in the risk direction in the overall cohort, with rs5370 and rs72735260 remaining significant after FDR correction.

  • The study included 300 adults aged 25-55 years: 150 with T2DM and 150 age- and sex-matched controls.
  • EVA (n=116) vs normal vascular aging (NVA, n=184) was classified using age-referenced estimated pulse wave velocity (ePWV).
  • Variants tested were ENHO rs2281997 and rs72735260 and EDN1 rs5370 and rs2070699, genotyped by HRM analysis with Sanger confirmation.

A higher Total genetic risk score (GRS) was associated with increased adjusted odds of EVA, with a graded increase across genetic burden categories.

  • Each additional risk allele in the Total GRS increased the adjusted odds of EVA by 69% (OR 1.691, 95% CI 1.381-2.094).
  • The odds increased in a graded way across genetic burden categories.

Gene-specific GRS were linked to their respective circulating biomarkers: higher ENHO-GRS with lower adropin and higher EDN1-GRS with higher endothelin-1.

  • Gene-specific and total GRS were tested against adropin, endothelin-1, the adropin-endothelin-1 imbalance index (AEI), EVA, and continuous ePWV.

Higher Total GRS was associated with a greater adropin-endothelin-1 imbalance index (AEI), which statistically mediated about half of the GRS-EVA association.

  • AEI statistically mediated 51.8% of the GRS-EVA association.

AEI discriminated EVA better than the genetic risk score within the study cohort.

  • AUC was 0.776 for AEI vs 0.661 for GRS.
  • This was an internal evaluation within the study cohort, without independent replication.

The authors conclude that independent replication is required before any clinical application.

  • Findings come from a single cohort of 300 adults aged 25-55 years.

What This Means

This study looked at whether inherited differences in two genes, ENHO (which makes adropin, a protein thought to protect blood vessels) and EDN1 (which makes endothelin-1, a molecule that constricts blood vessels), are linked to blood vessels aging earlier than expected. It included 300 adults aged 25-55, half with type 2 diabetes and half without. Early vascular aging was defined using an estimate of arterial stiffness based on age. The researchers found that all four gene variants they tested were linked to early vascular aging, and two stayed significant after statistical correction for multiple testing. Combining the variants into a genetic risk score, each additional risk allele raised the odds of early vascular aging by 69%. People with higher genetic scores tended to have lower adropin, higher endothelin-1, and a more unfavorable balance between the two. This imbalance statistically accounted for about half of the link between genetics and early vascular aging, and the balance measure distinguished people with early vascular aging better than the genetic score did. This research suggests that inherited variation may help shape a blood-vessel balance relevant to early vascular aging, in people both with and without diabetes. However, the study was in a single group of people and showed association, not proof of cause. The authors state that the findings need independent replication before being used clinically.

Have a question about this study?

Citation

Sivakumar R, Senghor K, Vinodhini V, Kumar J. (2026). ENHO and EDN1 variants link adropin-endothelin-1 imbalance with early vascular aging in adults with and without type 2 diabetes.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1961984